Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
PMID 23028239
In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
The most common ones among real-world patients seem to be headaches, nausea, dizziness, and injection site redness or irritation that should subside with use
Its the healing environment
Making Informed Decisions Therapeutic Value and Insurance: We work closely with you to weigh the benefits and costs of peptide therapies